Serum CEA values showed an upward trend from stage I to III with tumor progression, meanwhile, the expressions of AACT‐N106‐H7N6S4F1 increased in all three stages of GCs compared to HCs in the discovery cohort (Figure 4e). This evidence concerns the gene CEACAM5 and neoplasm.